Ismn Stada

Isosorbide mononitrate, the active ingredient in Ismn Stada, is a organic nitrate presented as an oral tablet for oral use. It is indicated for the prevention and treatment of angina pectoris in adults with chronic stable coronary artery disease.

GNH USA supplies Ismn Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isosorbide mononitrate is used in the management of coronary artery disease‑related angina.

- Chronic stable angina: reduces the frequency of angina attacks and improves exercise tolerance. - Prevention of angina pectoris: decreases episodes of chest pain during physical exertion. - Effort‑induced angina: provides prophylactic relief of exertional chest discomfort.

Isosorbide mononitrate may cause a range of adverse reactions.

Common Side Effects: - Headache: often mild to moderate and transient. - Dizziness or light‑headedness: related to blood pressure reduction. - Flushing: warm sensation of the skin, especially on the face. - Nausea: occasional gastrointestinal upset.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure requiring medical attention. - Syncope: fainting episodes due to inadequate cerebral perfusion. - Life‑threatening arrhythmias: irregular heart rhythms that may be fatal if untreated.

Before initiating therapy, consider the following safety measures.

- Dose titration: start with a low dose and increase gradually as tolerated. - Avoid concurrent PDE‑5 inhibitors: risk of profound hypotension. - Renal impairment: adjust dose or monitor renal function closely. - Hepatic impairment: use with caution and monitor liver function. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Isosorbide mononitrate can interact with several drug classes.

Major Interactions (Avoid): - Sildenafil and other PDE‑5 inhibitors: may cause severe hypotension. - Other organic nitrates (e.g., nitroglycerin): additive vasodilatory effect leading to dangerous blood pressure drops. - Antihypertensive agents (ACE inhibitors, beta‑blockers): may enhance blood‑pressure‑lowering effects.

Moderate Interactions (Monitor Closely): - Diuretics: increase risk of orthostatic hypotension. - Alcohol: can potentiate vasodilatory effects and dizziness.